Amneal Pharmaceuticals (AMRX) EBITDA (2017 - 2026)
Amneal Pharmaceuticals (AMRX) recorded EBITDA of $177.57 million in Q2 2026, up 3.5% from $171.49 million a year earlier but down 4.0% from the prior quarter.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) EBITDA (2017 - 2026) Analysis & Trends
On a TTM basis, Amneal Pharmaceuticals' EBITDA came in at $648.21 million as of Jun 30, 2026, up 4.3% year-over-year; for FY2025, it came in at $617.67 million, up 27.2% from FY2024.
- Annual EBITDA has increased for three straight years, with a five-year compound annual growth rate of 13.6% (FY2020 to FY2025).
- Across earlier years, EBITDA came in at $485.52 million in FY2024 (+11.9%), $433.77 million in FY2023 (+198.6%), $145.25 million in FY2022 (-62.4%) and $386.12 million in FY2021 (+18.2%).
- Quarterly EBITDA has ranged from -$138.92 million in Q2 2022 to $184.96 million in Q1 2026 over the past five years.
- On a year-over-year basis, EBITDA has increased for three consecutive quarters, with growth averaging 49.9% over the last eight quarters.
- Peak year-over-year performance for EBITDA in the last five years was growth of 258.4% in Q1 2025, against a decline of 51.6% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $184.96 million (Q1 2026), $161.26 million (Q4 2025) and $124.42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Amneal Pharmaceuticals | 6.55 Bn | 5.82 Bn | 334.51 Mn | 177.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 177.57 Mn |
| Mar 31, 2026 | 184.96 Mn |
| Dec 31, 2025 | 161.26 Mn |
| Sep 30, 2025 | 124.42 Mn |
| Jun 30, 2025 | 171.49 Mn |
| Mar 31, 2025 | 160.51 Mn |
| Dec 31, 2024 | 141.92 Mn |
| Sep 30, 2024 | 147.77 Mn |
| Jun 30, 2024 | 151.04 Mn |
| Mar 31, 2024 | 44.78 Mn |
| Dec 31, 2023 | 71.13 Mn |
| Sep 30, 2023 | 132.85 Mn |
| Jun 30, 2023 | 137.20 Mn |
| Mar 31, 2023 | 92.60 Mn |
| Dec 31, 2022 | 97.09 Mn |
| Sep 30, 2022 | 105.96 Mn |
| Jun 30, 2022 | -138.92 Mn |
| Mar 31, 2022 | 81.12 Mn |
| Dec 31, 2021 | 72.36 Mn |
| Sep 30, 2021 | 88.70 Mn |
API Access
Amneal Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=AMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();